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Growth factor-mediated phosphorylation of proapoptotic BAD In all three of these disorders, long-term prognosis for
reduces tubule cell death in vitro and in vivo. progression or recovery greatly depends on the severity
Background. Exogenous growth factors administered during of tubular injury. Obstructed flow increases intratubularunilateral ureteral obstruction (UUO) in neonatal rats signifi-
hydrostatic pressure causing tubular epithelial cell stretchcantly reduce apoptosis and tubular atrophy. Because the
and secondary apoptosis [4–6]. The administration of ex-mechanism underlying these salutary effects is largely unknown,
we investigated signaling pathways potentially activated by ogenous growth factors [epidermal growth factor (EGF)
growth factors to determine their roles in therapeutic action. or insulin-like growth factor (IGF)] attenuated renal le-
Methods. Mechanical strain was applied to confluent cultures sions and improved renal function in animal models ofof immortalized rat proximal tubule cells to simulate obstruc-
urinary tract obstruction [7, 8], polycystic kidney diseasetion-induced stretch injury in vivo. Growth factors, inhibitory
[9] and ischemic acute renal failure [10]. However, theantibodies or pharmacological inhibitors were added to cul-
tures that were subsequently processed for TUNEL analysis cellular mechanisms underlying these salutary effects re-
or immunoblots to identify signaling pathways that could be main poorly understood.
modulating cell survival. For in vivo studies, kidneys harvested
In theory, the administration of mitogenic growth fac-from ratsUUO epidermal growth factor (EGF) were fixed
tors to animals with unilateral ureteral obstruction (UUO)or frozen for immunohistochemistry or immunoblot analysis.
Results. Treatment with EGF or insulin-like growth factor-1 should promote tissue regeneration. EGF and IGF-1
(IGF-1) during stretch decreased apoptosis by 50% (P  mRNA expression increases throughout nephrogenesis
0.001). Neutralizing antibodies (Abs) directed against either in the neonatal rat, indicating that these growth factors
growth factor or its receptor blocked the reduction in apoptosis.
may be important for renal growth and developmentStretch decreased BAD phosphorylation by50% (P 0.001)
[11, 12]. In contrast, renal EGF mRNA declines rapidlyrelative to unstretched cells and each growth factor restored
phosphorylation to basal levels. Kinase-specific inhibitors that in neonatal rats subjected to UUO on the first day of life
blocked growth factor-mediated BAD phosphorylation pro- [12]. Administration of EGF to obstructed neonatal rats
moted apoptosis in vitro. BAD phosphorylation decreased by significantly reduced tubule cell apoptosis by 80% in neo-
50% (P 0.001) in the tubules of obstructed hydronephrotic
nates [8] and by 50% in adults [13], relative to untreatedrat kidneys and administration of EGF restored BAD phos-
UUO animals. This suggests that exogenous EGF re-phorylation to basal levels.
stored homeostasis and/or processes essential for renalConclusions. Signaling pathways converging at BAD phos-
phorylation are key to growth factor-mediated attenuation of development. IGF also reduced epithelial cell apoptosis
stretch-induced apoptosis in vitro and in vivo. and tubular atrophy by 40 to 50% in neonatal UUO rats
[7]. Although proliferation is presumed to be the mecha-
nism of growth factor action in the preservation of renal
Obstruction to intratubular flow is the consequence of tissue after injury, there is no direct evidence that this
several major renal disorders: obstructive nephropathy, is the case.
polycystic kidney disease and acute renal failure [1–3]. We have characterized a renal cell model of stretch
injury that recapitulates some aspects of tubular cell in-
jury during UUO in vivo. The purpose of this study wasKey words: apoptosis, mechanical stress, ureteral obstruction, epider-
mal growth factor, p42 MAP kinase. to validate the in vitro model by comparing it to previous
work with growth factors in animals and to extend thatReceived for publication May 14, 2002
work by defining mechanisms of action. To do this,and in revised form July 22, 2002
Accepted for publication August 12, 2002 growth factors were added to culture medium during a
stretch-injury protocol and cell death was monitored as 2003 by the International Society of Nephrology
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an end point. EGF and IGF effectively reduced tubule kinase (MEK) inhibitor PD98059 and phosphatidylinositol
cell apoptosis due to stretch injury in vitro, in agreement 3-kinase (PI3K) inhibitor LY294002 (Calbiochem Corp.)
with results previously reported in neonatal rats [7, 8]. were added to cultures at a final concentration of 20mol/L
To define underlying processes affected by both injury two hours prior to growth factor addition with or without
and therapy, we studied the signaling pathways activated stretch.
by stretch-injury, as well as by growth factor receptor
Stretch protocolactivation. The results demonstrate that both stretch- and
obstruction-induced tubular cell injuries induce the de- For each plate of cells and treatment conditions desig-
phosphorylation of BAD. Dephosphorylated BAD asso- nated for stretch, an identical control plate was prepared
ciates with BclXL on the outer mitochondrial membrane, without stretch. Static stretch was applied to Bioflex
causing the release of cytochrome C and initiating apo- plates with a FX-3000 Flexercell Strain Unit (Flexcell
ptosis [14, 15]. In contrast, growth factor receptor activa- International Corp.), increasing the percent elongation
tion stimulates the activity of several downstream ki- (degree of stretch) from zero to 20% at 0.22%/min dur-
nases that phosphorylate BAD, restoring homeostatic ing the first hour, then holding at 20% elongation for
phosphorylation levels. Once phosphorylated, BAD as- three hours. This was done to simulate rising hydrostatic
sociates with 14-3-3 chaperone proteins that keep it se- pressure within the tubule as urinary tract obstruction
questered in the cytoplasm and away from mitochondria develops, followed by sustained pressure once obstruc-
[15]. Thus, EGF and IGF attenuate tubule cell apoptosis tion is complete [17, 18]. At the end of the four-hour
by shifting the balance of signals within injured cells to protocol, percent elongation was decreased to zero over
favor survival. a 10-minute period before removing plates from the vac-
uum manifold.
METHODS
Cell fixation and staining for apoptosis
Cell culture, growth factors and inhibitors
Cell monolayers were rinsed twice with phosphate-
Temperature-sensitive SV-40 immortalized rat proxi- buffered saline (PBS), fixed with 3.7% paraformaldehyde/
mal tubule cells (IRPTC) were grown in complete me- PBS for five minutes at room temperature and perme-
dium at a permissive temperature as described [16]. For abilized with ethanol/acetic acid (2:1) for three minutes
experiments, 2  105 IRPTC cells were seeded to each at 20C. Cloning rings (10 mm) were used to isolate
well of collagen type I coated Bioflex plates (Flexcell
areas on the flexible membrane for TUNEL (terminal-
International Corp, Hillsborough, NC, USA). Confluent
deoxynucleotidyl-transferase uridine-triphosphate nickcultures were shifted to 41C, a non-permissive tempera-
end labeling) staining with ApopTag Red (Intergen Co.,ture, for 16 hours to shut off the transformed phenotype
Purchase, NY, USA). Staining was performed accordingand induce normal epithelial cell differentiation prior to
to manufacturer’s recommendations and coverslips werethe start of each experiment. Cell culture experiments
mounted with Aqua Polymount (Polysciences, Inc., War-were routinely conducted at 41C using reduced serum
ington, PA, USA). Positively stained nuclei were countedmedium [supplemented with 1% fetal bovine serum (FBS),
at 200 magnification in at least 10 non-overlapping5g/mL insulin, 5g/mL transferrin and 50 nmol/L hydro-
fields from two different areas of the flexible membranecortisone]. Recombinant human EGF (Upstate Biotech-
to determine the mean number of apoptotic nuclei pernology Inc, Lake Placid, NY, USA) or IGF (a gift from
field. The Student t test was performed to determine theGenentech Inc., San Francisco, CA, USA) were added
statistical significance of differences between control andto cultures at a final concentration of 20 ng/mL at the
experimental groups.start of stretch procedures. Neutralizing rabbit anti-EGF
(10 g/mL) or mouse anti-IGF-1 (20 g/mL) antibodies
Preparation of cell lysates and cytosols
(Abs; Upstate Biotechnology Inc.) were preincubated
Cell lysates were prepared as described [19], adjustingwith 20 ng/mL of the appropriate growth factor in medium
the protease and phosphatase inhibitor content of lysisfor 30 minutes before adding to cell cultures. Normal
buffer to: 5 mmol/L benzamidine, 50g/mL each leupep-mouse IgG (20 g/mL; Jackson ImmunoResearch Labor-
tin, aprotinin, and trypsin inhibitor, 5 g/mL pepstatin,atoies Inc., West Grove, PA, USA), neutralizing anti-EGF
1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 20receptor (anti-EGFR) monoclonal antibodies (mAb; 10
mmol/L sodium fluoride, 1 mmol/L sodium vanadate, 1g/mL; Upstate Biotechnology Inc.) or anti-IGF recep-
mmol/L para-nitrophenylphosphate and 5 mmol/L imid-tor (anti-IGFR) mAb (1 g/mL; Calbiochem Corp., San
azole. Cell cytosols were prepared as described [20] butDiego, CA, USA) were added to medium and then to cell
with 10 to 15 strokes of an “A-type” pestle in a Douncecultures 30 minutes prior to growth factor addition and
homogenizer, monitoring the extent of lysis by micro-the initiation of stretch. Mitogen-activated protein ki-
nase (MAPK)–extracellular signal-related kinase (ERK) scopic examination every five strokes. Samples were nor-
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malized by protein concentration and solubilized with [8]. One neonatal rat underwent sham operation as an
additional control. All five animals were sacrificed onboiling Laemmli buffer.
day 8, both kidneys were harvested, weighed, cut in half
Gel electrophoresis and immunoblots and each half was flash frozen in liquid N2 before storing
at80C. Tissue homogenates were prepared on ice withCell proteins were separated on 10 to 15% acrylamide
gels by sodium dodecyl sulfate-polyacrylamide gel elec- a Polytron homogenizer, using 150 to 200 mg of frozen
tissue/mL homogenization buffer [20 mmol/L Tris-HCltrophoresis (SDS-PAGE) and then electrophoretically
transferred to nitrocellulose. Uniform protein loading (pH 7.4), containing 0.25 mol/L sucrose, 5 mmol/L ethyl-
enediaminetetraacetic acid (EDTA) and all the proteaseand transfer were determined by staining blots with 2%
wt/vol Ponceau s. in 5% acetic acid and destaining in and phosphatase inhibitors listed in the preparation of
cell lysates]. Samples (50 g protein/lane for BAD Ab5% acetic acid until protein bands were visible [21, 22].
Ponceau staining was reversed with several phosphate- and 80 g protein/lane P-BAD Ab) solublized in boiling
Laemmli buffer were separated by SDS-PAGE on 12.5%buffered saline (PBS) washes to neutralize acid prior to
blocking step. After blocking nitrocellulose in 5% nonfat acrylamide gels and transferred to nitrocellulose for im-
munoblot analysis with anti-BAD and anti-P(ser112)-dry milk for 30 minutes, blots were incubated with agita-
tion overnight at 4C with one of the following antibodies BAD antibodies. Immunoblots were developed with ECL
reagents mixed in dark room immediately before usediluted in 20 mmol/L Tris-HCl, pH 7.4, 0.5 mol/L NaCl,
1% wt/vol BSA and 0.02% wt/vol sodium azide: Cell Sig- and film was exposed for a minimum of five hours for
P-BAD. Densitometry values from two different blotsnaling Technology’s rabbit anti-p44/p42MAPK Ab [1:500],
mouse anti-phospho(P-thr202/tyr204)MAPK mAb (1:300), (exposed to the same piece of film) were pooled for a
paired Student t test to determine the statistical signifi-rabbit anti-Akt Ab (1:500), rabbit anti-phospho(P-ser473)
Akt Ab (1:500), and mouse anti-phospho(P-ser112)BAD cance of differences between control (IO) and experi-
mental (UUO) groups  EGF.mAb (1:100); Transduction Laboratories’ mouse anti-BAD
(clone 48) mAb (1:100) and Pharmingen’s mouse anti-
cytochrome C mAb (2 g/mL). Immunoreactive bands
RESULTS
were visualized with enhanced chemiluminescence (ECL)
To test the hypothesis that hydrostatic pressure-inducedreagents according to the manufacturer’s recommenda-
strain on tubular cells causes the early lesions of obstruc-tions and relative band intensity was determined on a
tive nephropathy, we used a Flexercell Strain Unit to simu-Molecular Dynamics densitometer.
late obstruction-induced tubule stretch in vivo. Proximal
3H-thymidine incorporation assay tubule cells were chosen for this study because obstructed
nephron intratubular pressures and the time course of pres-3H-thymidine [1 Ci/mL] was added to triplicate wells
sure changes were available for proximal, but not distal orfor six hours following the stretch/non-stretch protocol.
collecting duct tubules [18] and because TUNEL stainingCell monolayers were then washed three times with PBS
coincident with Lotus tetragonolobus lectin staining hascontaining 1 mmol/L CaCl2, precipitated with cold 15%
been observed in the cortex of neonatal obstructed ratwt/vol trichloroacetic acid for 30 minutes at 4C and
kidneys [8]. Tubule wall tension (degree of stretch) hasair-dried overnight. Flexwell bottoms were cut out and
not been measured for any nephron segment during ob-counted in a liquid scintillation counter to determine
struction. Therefore, we developed in vitro stretch condi-total cpm/well.
tions that would closely approximate the percentage of
Immunohistochemistry TUNEL-positive cells/field detected in an obstructed neo-
natal rat kidney. TUNEL-positive (apoptotic) cells in-Anti-P(ser112)-BAD mAb (Cell Signaling Technol-
creased proportionately with time and the degree of staticogy) staining of formalin-fixed, paraffin-embedded rat
axial strain applied to confluent IRPTC cultures (manu-kidney sections (tissue blocks from a previously pub-
script in preparation; S.C. Kiley). Twenty percent axiallished study [8]) was performed according to manufactur-
elongation for four hours consistently produced a sig-er’s recommendations using a 1:50 dilution of the pri-
nificant number of apoptotic cells relative to control. Un-mary antibody. Sections from at least three kidneys per
der these conditions, approximately 20% or an averageexperimental group were examined.
of 40 cells in a field of 200 were apoptotic (Fig. 1), a result
Kidney homogenates and Western blots that is comparable to the 16 to 20% tubule cells that are
TUNEL-positive in UUO kidney sections from 7-dayTo obtain tissue for immunoblot analysis, four neona-
old mice (unpublished observation; B. Lange-Speran-tal Sprague-Dawley rats underwent unilateral ureteral
dio). The addition of either EGF or IGF-1 to culturesobstruction (UUO) of the left kidney one day after birth;
undergoing stretch reduced apoptosis by 50% (P two of these animals were infused daily with EGF for
seven days and the other two were infused with vehicle 0.001) relative to cell-stretch in the absence of either
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Fig. 1. Epidermal growth factor (EGF) and insulin-like growth factor
(IGF) attenuate mechanical stretch-induced apoptosis. (A ) TUNEL
Fig. 2. Neutralizing antibodies block the anti-apoptotic effects of epi-staining of non-stretched control immortalized rat proximal tubule cells
dermal growth factor (EGF) (A ) and IGF (B ). Pre-incubation with(IRPTC) and IRPTC cells subjected to 20% axial stretch for four hours
nonspecific mouse (ms) IgG or neutralizing Ab for growth factor orin the absence or presence of EGF or IGF. (B ) TUNEL-positive cells
growth factor receptor preceded the four-hour stretch protocol andwere counted as described in Methods section with statistical differences
growth factor addition as described in Methods section. Apoptotic nu-determined by Student t test. Symbols are: ( ) control; ()  EGF;
clei were counted in 10 non-overlapping fields and statistically significant( )  IGF. Statistically significant comparisons are shown relative to
differences were determined by the Student t test. These results have20% stretch control; ***P  0.001 and error bars indicate SE from
been reproduced in 3 experiments.mean. Similar results were achieved in 6 independent experiments.
Results shown in Figure 2A demonstrate that EGF atten-growth factor. Since EGF-treatment of adult UUO rats
uation of stretch-induced apoptosis is completely re-reduced tubular cell apoptosis by 50% [13] and IRPTC
versed in the presence of anti-EGF or anti-EGFR Ab.cells were derived from young adult rats, this result sup-
Inclusion of a nonspecific control Ab (normal mouseports the use of the in vitro model for the parameters
IgG) did not alter the EGF-mediated reduction in apo-under study.
ptosis (P 0.001 vs. P 0.001 for EGF alone, relative toTo determine if EGF and IGF are protecting cells
untreated control or EGF with neutralizing Ab groups).directly through receptor-coupling, neutralizing antibod-
Similar results were found with IGF in the presence ofies to either growth factor or its receptor were included
along with growth factor during the stretch protocol. anti-IGF or anti-IGFR Ab (Fig. 2B). This indicates that
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cultures (Fig. 3A, right). In the absence of growth factor
addition, stretch increases P-MAPK (thr202/tyr204) and
P-Akt (ser473), indicating that these survival kinases
are activated in response to injury. Stretch injury also
induces the dephosphorylation of BAD. Results from
these immunoblots indicate that the injury-induced ki-
nase activities may be insufficient to counteract the phos-
phatase activity dephosphorylating BAD.
The addition of EGF to IRPTC cultures is a potent
stimulus for MAPK activation, but also increases P-Akt
twofold via activation of PI3K in a parallel pathway.
Stretch plus EGF appear to be additive activation signals
for Akt, together increasing P-Akt fourfold according to
densitometry values. Although stretch decreases EGF-
induced P-BAD relative to EGF alone, the level of
P-BAD remains twice basal level (Fig. 3B) and this could
significantly reduce apoptosis via the mitochondrial death
pathway. In contrast to EGF, IGF is a potent stimulus
for the PI3K/Akt pathway and does not activate MAPK
in IRPTC. The level of P-BAD achieved in the presence
of IGF and stretch is about half basal level, which may
be sufficient to reduce BAD/BclXL mediated apoptosis
and promote cell survival.
To determine if MAPK or Akt survival pathways are
required in EGF/IGF attenuation of stretch-induced
apoptosis, we pretreated cells with pathway-specific, cell
permeant inhibitors prior to stretch and growth factor
Fig. 3. Mechanical stretch and growth factors activate signal transduc-
addition. PD98059 inhibits the MAPK pathway by spe-tion pathways that influence the phosphorylation state of BAD. (A )
Immunoblots of cell lysate proteins (50 g/lane) prepared from non- cifically inactivating MEK, the kinase that directly phos-
stretched and stretched cultures  growth factor were probed with phorylates and activates MAPK [23–25]. LY294002 in-
antibodies specific for non-phosphorylated or phosphorylated (P) forms
hibits the Akt pathway by specifically inactivating theof MAPK, Akt and BAD, as indicated. (B ) Quantitative differences
in P-BAD band intensity (A) were determined by densitometry and catalytic subunit of PI3K [26], preventing PDK phos-
are shown graphically. Symbols are: ( ) control; ()  EGF; ( )  phorylation and downstream activation of Akt. The im-
IGF. Similar results were produced in three independent experiments.
munoblots shown in Figure 4A (left) demonstrate that
stretch, growth factors and inhibitors had no effect on
total MAPK and Akt protein expression, whereas the
blots on the right demonstrate that all of the treatmentsprotection conferred by EGF and IGF is mediated by
direct ligand-receptor binding and probably involves sig- exerted predicted effects on modulating the phosphory-
lation state of those kinases in IRPTC cells. Stretch in-naling pathways downstream of tyrosine kinase receptor
activation. creased P-MAPK and P-Akt relative to unstretched cells
(compare lane 1 and lane 6), as previously shown in FigureSeveral signal transduction pathways that promote cell
growth and survival lie downstream of the EGF and IGF 3A. EGF substantially increased P-MAPK ( stretch)
and MEK inhibitor PD98059 pretreatment decreasedreceptor tyrosine kinases. To identify which of these
pathways are activated in IRPTC by mechanical stretch EGF induction of P-MAPK by 66%. P-Akt was pri-
marily increased by IGF treatment and pretreatmentand/or the addition of growth factors, blots of whole cell
lysates were prepared and probed with antibodies that with LY294002 inhibited this response by 80%. Thus,
pretreating IRPTC cells with PD98059 will primarily in-recognize total immunoreactive protein regardless of
phosphorylation status or that are phosphorylation state- hibit MAPK-mediated signaling and pretreating with
LY294002 will inhibit survival pathways that are depen-specific. As shown in Figure 3A (left), p44/p42 MAP
kinase (MAPK), Akt and the proapoptotic protein BAD dent on PI3K activation, that is, Akt. PD98059 pretreat-
ment completely reversed the EGF-mediated decreaseare all expressed in IRPTC cells and the levels of total
immunoreactive proteins do not change regardless of in stretch-induced apoptosis (Fig. 4B). PD98059 and
LY294002 were used in combination with EGF, but sincestretch or growth factor addition. In contrast, the phos-
phorylation state of these proteins changes with mechan- reversal was maximal with PD98059 alone, no further
change was noted (data not shown). LY294002 pretreat-ical stretch and again with growth factor addition to
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Fig. 4. Kinase-specific inhibitors block growth
factor-mediated attenuation of apoptosis, with
no effect on 3H-thymidine uptake. Triplicate
IRPTC culture plates were pretreated 
PD98059 (PD) or LY294002 (LY) as de-
scribed in Methods, prior to growth factor
treatment and/or stretch. (A ) Cell lysates pre-
pared from triplicate wells/condition (50 g/
lane) were analyzed by immunoblot with non-
phospho and phospho (P)-specific MAPK and
Akt Abs to confirm that PD and LY inhibited
predicted signaling pathways. The partial un-
marked lanes seen on the extreme right are
positive control lanes for the phosphorylation
state-specific Abs. (B ) TUNEL-positive (apo-
ptotic) nuclei were counted in triplicate wells
for control and experimental conditions; sta-
tistical differences were determined as pre-
viously described. (C) 3H-thymidine was added
to 3-wells/condition for an additional six-hour
incubation after the growth factor/stretch pro-
tocol. Symbols are: () no stretch; ( ) 20%
stretch. Results are shown as the mean acid-
precipitable cpm from triplicate wells  SE.
Results shown are from one representative
experiment and were reproduced in two addi-
tional experiments.
ment prevented the IGF-mediated reduction in apopto- tors did not stimulate re-entry into the cell cycle under
these conditions (Fig. 4C). In contrast, stretch  growthsis (Fig. 4B). Together these data confirm that the MAPK
pathway is essential for EGF-mediated IRPTC survival factors and/or inhibitors induced proliferation. Mechani-
cal stretch-induced proliferation is well documented inand that the PI3K/Akt pathway is essential for IGF-
mediated IRPTC survival after stretch-induced injury. a variety of cell types [27–29]. Although EGF and IGF
may promote proliferation once the cells pass throughEpidermal growth factor and IGF can modulate cell
survival by promoting re-entry into the cell cycle or by crisis and survive, proliferation does not appear to be a
factor in achieving survival.promoting anti-apoptotic activities. Experiments were
performed to delineate these responses and determine Results shown in Figure 4C suggest that EGF and IGF
are more likely to influence cell survival by reducingwhich has the greater influence on survival. IRPTC cells
underwent stretch  inhibitor treatments  growth fac- apoptotic activity than by promoting proliferation. In
Figure 5A, cell lysates from the same experiment de-tors and were then incubated with 3H-thymidine for an
additional six hours to detect new DNA synthesis. picted in Figure 4 were analyzed for the effects of MAPK
and Akt pathway inhibitors on growth factor-inducedGrowth factors  MAPK or PI3K/Akt pathway inhibi-
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Fig. 6. P-BAD is exclusively detected in renal tubules and decreases
in dilated tubules of obstructed kidneys. Representative kidney sections
from one animal per group  EGF are shown at 140 magnification.
Obstructed (UUO) and control (intact opposite, IO) kidneys were
stained with mouse anti-P-BAD mAb, peroxidase-conjugated anti-
mouse IgG and developed with DAB. Sections were not counter-
stained. Arrows (←) indicate selected tubules positive for P-BAD stain-
ing; an asterisk (*) indicates tubules devoid of P-BAD staining; and G
indicates a glomerulus. A total of 3 kidney sections per group ( EGF)
were evaluated.
with a corresponding increase of cytochrome C detected
in the cytoplasm. Release of cytochrome C into the cyto-
plasm indicates mitochondrial injury and the initiation
of apoptosis. Densitometry values derived from these
immunoblots are plotted in Figure 5 B and C to illustrateFig. 5. Dephosphorylation of BAD correlates with cytochrome C re-
lease into cytosol. (A ) Cell lysates (50 g/lane) were prepared from the inverse relationship between P-BAD levels and cyto-
cultures treated as indicated and loaded onto 12.5% acrylamide gels chrome C release.for SDS-PAGE. Cell proteins were transferred to nitrocellulose for
Studies with our in vitro model suggest that the mecha-immunoblotting with BAD and P-BAD specific mAbs. Cytosols (30
g/lane) prepared by Dounce homogenization and high-speed centrifu- nism by which EGF and IGF attenuate stretch-induced
gation were separated on 15% gels, blotted and probed with anti- apoptosis in IRPTC involves regulation of BAD phos-cytochrome C mAb. (B and C) Densitometry values of immunoblots
phorylation. The question then becomes, did this mecha-in panel A. Symbols are: ( ) control; () EGF; ( ) PD/EGF; ( )
IGF; ( ) LY/IGF. The results shown are from one representative exper- nism also operate in animals with urinary tract obstruction
iment, but were verified in two additional experiments. that were given EGF daily? To answer this question we
sectioned formalin-fixed, paraffin-embedded kidney tissue
remaining from the published study [8] and stained the
phosphorylation of BAD. PD98059 and LY294002 did sections with mouse anti-P(ser112)-BAD mAb. P-BAD
not substantially reduce P-BAD levels in control (un- immunostaining was exclusively in the cytoplasm of proxi-
stretched) cultures, suggesting that a two-hour pretreat- mal and distal tubule epithelial cells (Fig. 6). Images shown
ment was not sufficient to displace phosphate groups on are of the cortical-medullary junction, with closely spaced
BAD under static conditions. However, when cells are tubules of the cortex (surrounding glomeruli) and less
stressed, phosphorylation and dephosphorylation events densely spaced tubules of the medulla stained positive
become dynamic. Under these conditions, both PD98059 for P-BAD. P-BAD antibody did not stain glomeruli,
blood vessels, interstitial cells or fibrosis. The upper leftand LY294002 reduced growth factor-stimulated P-BAD
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image (Fig. 6) is an obstructed kidney from an animal
that was not treated with EGF. Many dilated tubules are
evident both in the cortex and medulla of the obstructed
kidney and P-BAD staining is absent in roughly half of
these. Expanding interstitial fibrosis increases the spatial
separation of tubules in the medulla, so there are fewer
tubules per unit space and an apparent loss of tubules in
the UUO kidney. The lower left image is of an obstructed
kidney from an animal treated daily with EGF for seven
days. The architecture of the kidney is nearly identical
to that of control kidneys  EGF shown on the right.
EGF treatment of the obstructed animal restored or pre-
served P-BAD staining in all tubules, reduced persistent
tubule dilatation, and preserved tubule number/density.
This suggests that EGF modulation of P-BAD levels in
tubule cells may have played a role in reducing tubular
cell apoptosis in the UUO kidneys.
To quantitate the impact of EGF treatment on P-BAD
levels in neonatal rat kidney, EGF was administered to
neonatal rats for seven days  UUO to generate tissue
for immunoblot analysis with BAD and P-BAD mAbs.
Total immunoreactive BAD levels did not change in
UUO animals relative to Sham and intact opposite (IO)
controls  EGF (Fig. 7A). In contrast, P-BAD levels
Fig. 7. EGF-treatment restores P-BAD to control levels in obstructeddecreased twofold (P  0.001) in UUO kidneys relative
kidneys. (A ) Sham control (S), right-IO control and left-UUO kidneysto control IO kidneys of animals that were not treated
from animals treated  EGF were homogenized and homogenate pro-
with EGF. EGF administration did not change P-BAD teins were separated by SDS-PAGE before blotting to nitrocellulose.
Immunoblots were probed with either mouse anti-BAD or anti-P-BADlevels in Sham and IO kidneys, suggesting that BAD
mAb as indicated. The blots shown represent results obtained with 2is already maximally phosphorylated in normal kidney
different sets of samples and the band seen above *P-BAD is a nonspe-
tissue. However, in the UUO kidneys where P-BAD cific reactivity of the secondary ECL Ab. (B ) Densitometry values
pooled from 2 different P-BAD immunoblots demonstrate quantitativelevels decline, EGF treatment increased P-BAD 2-fold
differences in P-BAD levels of untreated vs. EGF-treated animals.(P 0.001) restoring homeostatic phosphorylation (Fig. 7). Symbols are: ( ) sham; ()  vehicle; ( )  vehicle; ( )  EGF;
Thus, growth factor administration during chronic injury ( )  EGF.
in vitro and in vivo attenuates apoptosis by increasing
phosphorylation of BAD, shifting it from a “proapo-
ptotic” protein capable of inducing mitochondrial dam-
free BAD to associate with BclX on the outer mitochon-age to an “anti-apoptotic protein” safely bound to chap-
drial membrane. Formation of the BAD/BclX complexerone proteins in the cytoplasm.
initiates apoptosis by altering mitochondrial membrane
permeability and causing the release of cytochrome C
DISCUSSION into the cytoplasm [14, 15]. Administration of EGF or
IGF during chronic injury activates protein kinases thatThe goal of the present study was to determine the
mechanism by which growth factors EGF and IGF atten- directly phosphorylate BAD and restore BAD associa-
tion with 14-3-3 proteins instead of BclX. Together theseuate stretch-induced tubule cell apoptosis. Our finding
that stretch injury triggers dephosphorylation of BAD results suggest that basal levels of BAD phosphorylation
are important for cell homeostasis and that by perturbingand consequently promotes apoptosis (Fig. 8) is superim-
posed on the work of those cited in this section. Mechani- the phosphorylation state of BAD, stretch-injury shifts
the balance from survival to favor death. EGF and IGFcal stretch in vitro or obstruction-induced stretch in vivo
activate a serine/threonine protein phosphatase activity counteract the stretch-activated phosphatase by activat-
ing kinases that phosphorylate BAD and shift the bal-that dephosphorylates Bcl2-related protein BAD. In an
“unstressed” cell, BAD is phosphorylated and bound by ance back to survival.
Epidermal growth factor was more effective than IGF14-3-3 chaperone proteins that sequester it in the cytosol
away from its apoptosis target, the mitochondria [15]. The in stimulating BAD phosphorylation, yet the net effect
on attenuation of apoptosis was the same. This can bedephosphorylation of BAD by protein phosphatases re-
sults in dissociation of the BAD/14-3-3 complex, allowing attributed in part to the properties of the phosphoryla-
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PI3K/Akt and PKA pathways, a total of three Ser resi-
dues may be phosphorylated on BAD as a consequence
of EGFR activation. Several commercial antibodies di-
rected against BAD P-Ser 136 or 155 failed to detect
endogenous phosphorylation at those sites (data not
shown). However, results shown in Figures 3A and 5A
indicate that the P-BAD(Ser 112) mAb detects IGF-
induced P-Ser 136 as well, though the affinity for the
secondary site may be reduced relative to Ser 112. This
general P-BAD specificity would best explain our finding
of two to three times more P-BAD in cells treated with
EGF than with IGF.
If EGF is three times more effective at inducing BAD
phosphorylation than IGF, why are the growth factors
comparable in attenuating apoptosis? In the rat proximal
tubule cells studied, EGF primarily activates the MAPK
pathway, with relatively small contributions from PKC or
PI3K in parallel pathways. More importantly, the MAPK
and PKC signaling pathways promote survival through
the phosphorylation of a single protein, BAD, and sec-
ondarily by promoting cell growth. In contrast, IGF acti-
vation of PI3K/Akt promotes the activation of multiple
survival pathways. Akt can reverse the proapoptotic ac-
tivity of BAD in all species studied to date and prevents
the cleavage of human (but not rodent) procaspase 9
[14, 36]. Akt is a key mediator of the metabolic effects
of insulin, stimulating glucose uptake by inducing the
Fig. 8. Shifting the balance between cell death and survival. (Top) translocation of the GLUT4 transporter to the plasma
Mechanical stretch injury induces activation of one or more phospha- membrane [37]. Akt also phosphorylates glycogen syn-tases, which in turn dephosphorylate BAD causing it to dissociate from
thase kinase-3, resulting in its inactivation and the conse-cytoplasmic 14-3-3 chaperone proteins. Dephosphorylated BAD then
forms a complex with BclX on the outer mitochondrial membrane, quent activation of glycogen synthase [38] and increases
altering membrane permeability. As a consequence, mitochondrial glycolysis by phosphorylating 6-phospho-fructo-2-kinase.membrane potential collapses and cytochrome C is released into the
Akt additionally up-regulates protein synthesis by regu-cytoplasm where it initiates apoptosis. (Bottom) Growth factors, EGF
or IGF, administered during stretch injury elevate MAPK and Akt lating the activity of ribosomal p70S6 kinase, a kinase that
kinase activity to levels that can compensate for the stretch-induced alters the pattern of protein synthesis after mitogenicphosphatase activity acting on BAD. As a result, BAD is phosphory-
stimulation [39] and also can regulate the transcriptionallated and sequestered by 14-3-3 proteins to restore homeostasis and
cell survival. activation of genes via nuclear factor-	B (NF-	B) [40].
The fact that IGF-induced Akt activation is key to the
activation more than six different survival-promoting
pathways accounts for comparable reductions in apopto-tion state-specific antibody used to study BAD and to the
sis by EGF and IGF, despite discrepancies in the extentnumber of sites phosphorylated in response to different
of BAD phosphorylation.signals. The antibody used to detect P-BAD in our stud-
We have shown that inducing BAD phosphorylationies is reportedly specific for only P-Ser 112; however, the
with exogenous growth factors during chronic injury inpolyclonal version of this antibody detected additional
vitro and in vivo improved tubule cell survival and re-P-serines on purified BAD protein [30]. EGF-induced
duced apoptosis by 50%. BAD is an attractive target foractivation of MAPK or protein kinase C (PKC) results
therapeutic intervention because the post-translationalin the activation of p90RSK, the kinase that directly
modification that alters its apoptotic activity is easilyphosphorylates BAD on Ser 112 [31, 32]. Protein kinase
induced and benefit is immediate. If we can find a meansA (PKA) directly phosphorylates BAD on Ser 112 and
of modulating other “death signaling pathways” to useSer 155 in response to EGF, platelet-derived growth
in combination with growth factors, we may eventuallyfactor (PDGF) or interleukin-3 (IL-3) stimulation [33, 34].
be able to prevent the permanent renal damage thatActivation of the PI3K/Akt pathway results in the phos-
occurs as a consequence of ischemic injury and/or ure-phorylation of BAD at only one site, Ser 136 [35]. Be-
cause EGF can simultaneously activate the MAPK, teral obstruction.
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